|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/48 | (2006.01) |
| A61K 9/145 | (2013.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61K 9/1623 | (2013.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 9/2846 | (2013.01) | ||
| A61K 9/4808 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/485 | (2013.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/4858 | (2013.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61K 9/4866 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61K 31/475 | (2013.01) | ||
| A61K 31/573 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Number of the document | 2575785 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11727917.4 |
| Date of filing the European patent application | 2011-06-01 | |
| (97) | Date of publication of the European application | 2013-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/002763 |
| Date | 2011-06-01 |
| (87) | Number | WO 2011/151086 |
| Date | 2011-12-08 |
| (30) | Number | Date | Country code |
| 11075046 | 2011-03-14 | EP | |
| 10005762 | 2010-06-02 | EP |
| (72) |
PATZAK, Ulrich , NL
OUATAS, Taoufik , NL
|
| (73) |
Pharma& Schweiz GmbH ,
Riedstrasse 1, 6330 Cham,
CH
|
| (54) | ORAL DOSAGE FORMS OF BENDAMUSTINE AND THERAPEUTIC USE THEREOF |
| ORAL DOSAGE FORMS OF BENDAMUSTINE AND THERAPEUTIC USE THEREOF |